First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
https://www.news-medical.net/n....ews/20240426/First-U
Discover the world at Altruu, The Discovery Engine